RxDoctor Payments Data

Arthur Decillis

Internal Medicine · Madison, CTNPI 1215202056

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,047,438 of the $1,048,251 with a category attached, or 99.9%. Alnylam Pharmaceuticals Inc. accounts for 74.5% of it on its own, with 2 other manufacturers making up the rest. Among internal medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,048,251in general payments, 2019–2025

Across 102 payments — averaging $10,277 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$781K
  • Exelixis Inc.$154K
  • Daiichi Sankyo Inc.$113K

What the payments were for

  • Consulting fees$1,047,438100%
  • Travel & lodging$2200%
  • Food & beverage$5930%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alnylam Pharmaceuticals Inc.43$781,190
Exelixis Inc.32$154,452
Daiichi Sankyo Inc.27$112,609

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,048,251 in reported general payments places this provider in the 95th percentile of 2,067 internal medicine providers in Connecticut.

See all internal medicine providers in Connecticut

Other internal medicine in Madison

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →